-
Altered Spontaneous Brain Activity in Essential Tremor with and without Resting Tremor: A Resting-state fMRI Study
-
Amantadine Therapy for Ataxia Management in Patients with Spinocerebellar Ataxia Type 7
-
Amantadine-induced negative myoclonus in a patient with Parkinson’s disease: A case report
-
Ambulatory Capacity Measure derived from the Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
-
Ambulosono: A Novel Sensor-based System for Quantitative Evaluation Freezing of Gait in Parkinson’s disease
-
Among Parkinson’s disease patients with both OFF and dyskinesia, ADS-5102 (amantadine) extended-release reduces disruptive motor episodes and improves function: Analysis of phase 3 trials
-
Amplitude training in Parkinson’s disease: Improved dressing independence
-
Ampreloxetine (TD-9855), a long-acting, norepinephrine reuptake inhibitor (NRI) for the treatment of neurogenic orthostatic hypotension (nOH) in subjects with synucleinopathies: Phase 3 clinical program
-
An aberrant embouchure dystonia network predicts objective and functional measures of severity
-
An agent-based model replicates the pathogenic spread of alpha-synuclein in mice
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 149
- Next Page »